Renin-angiotensin system antagonists, glomerular filtration rate and blood pressure
Journal Title: Нирки - Year 2018, Vol 7, Issue 1
Abstract
The article deals with the mModern data on the influence of renin-angiotensin system blockers on the glomerular filtration rate, the level of arterial pressure and the outcome of chronic kidney disease. The strategy of rennin-angiotensine blockade is offered to be changed depending on the criteria values of glomerular filtration rate: a combination of inhibitors of angiotensin-converting enzyme + angiotensin receptors blockers, monotherapy and drug withdrawal in glomerular filtration rate under 15–30 ml/min/m2. The formula BRIMONEL for treatment of chronic kidney disease is given.
Authors and Affiliations
D. D. Ivanov
Keywords
Related Articles
- EP ID EP265052
- DOI 10.22141/2307-1257.7.1.2018.122214
- Views 100
- Downloads 0
Active Follow-up in Patients with Localized Prostate Cancer: Evaluation of Long-term Results
Among the clinical recommendations one of the standard approaches in the treatment of prostate cancer is active follow-up. For 13 years, under the supervision there were 85.7 % of patients. Overall 3-, 5- and 7-year surv...
Kidneys and Diabetes Mellitus Type 2
.
Kidney Transplantation from АВ0-Incompatible Living Family Donor
The introduction into the clinical practice of kidney transplantation from АВ0-incompatible living donor may be one of the ways to solve the problem of shortage of cadaveric donor organs. The objective of this study was...
Candesartan in nephrological practice
First-line drugs in the treatment of hypertension in patients with chronic kidney disease is an angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. The topic of the article is devoted to compar...
The use of immunobiological monoclonal antibody-based drugs in nephrological practice
With various diseases of the kidneys, immunobiological monoclonal antibody-based therapy with a different mechanism of action is successfully used. These drugs include: rituximab (interaction with the CD20 receptor and e...